Breast, lung cancer incidence to rise due to COVID screening delays
The incidence of breast, colorectal, and lung cancer will likely rise due t...Read more on AuntMinnie.comRelated Reading:
SPECT/CT shows lung abnormalities in children with long COVID
PET/CT reveals different reactions to COVID-19 vaccines
ACS: COVID-19 increased deaths from cancer as contributing factor
Chest x-rays predict outcomes in hospitalized COVID-19 patients
PET/CT reveals how COVID-19 manifests in critically ill patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 30, 2023 Category: Radiology Source Type: news
Military members half as likely as civilians to receive HPV vaccine
Active-duty military and veterans are twice as likely as civilians to develop cancers associated with human papillomavirus, or HPV. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 28, 2023 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
The COVID-19 virus mutated to outsmart key antibody treatments. Better ones are coming
In 2020, as the COVID-19 pandemic raged and other effective drugs were elusive, monoclonal antibodies (mAbs) emerged as a lifesaving treatment. But now, 3 years later, all the approvals for COVID-19–fighting antibodies have been rescinded in the United States, as mutations of the SARS-CoV-2 virus have left the drugs—which target parts of the original virus—ineffective.
Researchers around the globe are now trying to revive antibody treatments by redesigning them to take aim at targets that are less prone to mutation. “There are new approaches that present a much more challenging task for the virus to evade,”...
Source: ScienceNOW - May 24, 2023 Category: Science Source Type: news
An African Country Faces Challenges to Protect Girls From HPV
Almost all cervical cancer deaths now occur in developing countries. Tanzania is trying to inoculate girls against the virus that causes the disease — nearly 20 years after rich countries began offering the shot. (Source: NYT Health)
Source: NYT Health - May 23, 2023 Category: Consumer Health News Authors: Stephanie Nolen Tags: Sexually Transmitted Diseases Vaccination and Immunization Cervical Cancer Rumors and Misinformation Human Papillomavirus (HPV) Developing Countries Gardasil (Vaccine) Gavi, the Vaccine Alliance Tanzania your-feed-healthcare your-feed- Source Type: news
An mRNA vaccine to treat pancreatic cancer
A personalized mRNA vaccine against pancreatic cancer created a strong anti-tumor immune response in half the participants in a small study. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - May 22, 2023 Category: Consumer Health News Source Type: news
FDA advisers agree maternal RSV vaccine protects infants, but are divided on its safety
A committee of advisers to the U.S. Food and Drug Administration (FDA) yesterday voted unanimously that a vaccine from Pfizer, given as an injection during pregnancy, is efficacious at protecting infants from severe respiratory syncytial virus (RSV) disease during the first 6 months of life. If approved by the agency, the vaccine would a major advance against a disease that is the leading cause of hospitalization of U.S. infants. But troubled by side effect data from Pfizer’s trials and by another big drugmaker’s abandonment of a similar vaccine given during pregnancy, the panel split on the question of the vaccine’s...
Source: ScienceNOW - May 19, 2023 Category: Science Source Type: news
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
‘ What Price Was My Father ’ s Life Worth? ’ Right-Wing Doctors Are Still Peddling Dubious COVID Drugs
Julie Moore keeps an orange plastic bottle on her desk in Gas City, Indiana, with 14 round white pills. The other 21, she says, killed her father.
Moore remembers laughing when she first heard on the news that people were taking ivermectin, an anti-parasitic drug commonly used as a livestock dewormer, to treat COVID-19. She never expected her father, a career pharmacist, to become one of them.
Over the course of the pandemic, Moore’s father started watching online videos of doctors in white coats who claimed that alternative COVID treatments were being used effectively in India. He told his skeptical children that th...
Source: TIME: Health - May 15, 2023 Category: Consumer Health News Authors: Vera Bergengruen Tags: Uncategorized feature Misinformation & Disinformation uspoliticspolicy Source Type: news
mRNA Vaccine Promising for Pancreatic Cancer
(MedPage Today) -- A personalized mRNA vaccine, used in combination with an immune checkpoint inhibitor and chemotherapy after surgery, induced an immune response in half of treated patients with pancreatic ductal adenocarcinoma (PDAC), a small... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 11, 2023 Category: Gastroenterology Source Type: news
Vaccine Slows Return of Pancreatic Cancer in Early Trial
THURSDAY, May 11, 2023 – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial.
The mRNA vaccine, which was tailored to the genetic makeup of each patient ' s tumor, worked in half... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 11, 2023 Category: General Medicine Source Type: news
An mRNA vaccine that programs the body to fight pancreatic cancer shows early promise
Of the 16 patients who were able to complete all phases of the study, eight responded to the vaccine, which taught their immune systems how to recognize and fight off the cancer cells. None of those eight has seen their cancer return. (Source: CNN.com - Health)
Source: CNN.com - Health - May 11, 2023 Category: Consumer Health News Source Type: news
Moderna's Revolutionary Cancer Vaccine Sets Investors Abuzz
Medical researchers are using what they know about our immune system and computers to make startling advances. There has never been a better time for investors. Shares of Moderna (MRNA) closed Tuesday up 19.6% after company executives announced a jointly developed vaccine showed great efficacy…#moderna #mrna4157v940 #merck #rna #cambridge #pfe #keytrudamercks #keytruda #stephanebancel #bancel (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2023 Category: Consumer Health News Source Type: news
Pancreatic cancer vaccine prevents HALF of patients' tumors returning
The German firm BioNTech has led research into the development of a new breakthrough vaccine for pancreatic cancer. It prevented the disease from returning in half of patients. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2023 Category: Consumer Health News Source Type: news
Pancreatic Cancer Vaccine Shows Promise in Small Trial
Using mRNA tailored to each patient ’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it. (Source: NYT Health)
Source: NYT Health - May 10, 2023 Category: Consumer Health News Authors: Benjamin Mueller Tags: Vaccination and Immunization Pancreatic Cancer Tumors Research RNA (Ribonucleic Acid) Immune System BioNTech SE your-feed-science Source Type: news
Women Should Start Getting Mammograms at 40, Not 50, U.S. Health Panel Recommends
WASHINGTON — Women should start getting every-other-year mammograms at age 40 instead of waiting until 50, according to a draft recommendation from a federal task force.
The U.S. Preventive Services Task Force has long said women can choose to start breast cancer screening as young as 40, with a stronger recommendation that they get the X-ray exams every two years from age 50 through 74.
Tuesday’s update—if the draft proposal is finalized—would mark a shift in the influential panel’s guidelines although it’s not likely to end confusion. Other health groups differ over when and how often ...
Source: TIME: Health - May 9, 2023 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized Cancer healthscienceclimate wire Source Type: news
